Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 7 de 7
Filter
Add more filters










Database
Language
Publication year range
1.
Int J Nanomedicine ; 16: 1157-1174, 2021.
Article in English | MEDLINE | ID: mdl-33623380

ABSTRACT

INTRODUCTION: Candida albicans is a major opportunistic pathogen that causes a wide range of human infections. Currently available therapeutic agents are limited for treating these fungal infections due to multidrug resistance as well as their nonbiodegradability, poor biocompatibility and toxicity. In order to battle these limitations, we have synthesized a polymeric system as microcarriers to deliver the antifungal drug. The objective of the present study was to immobilize MgO/CuO nanocomposite and nystatin-loaded MgO/CuO nanocomposites in nontoxic, nonimmunogenic, biodegradable and biocompatible sodium alginate microspheres for the first time. MATERIALS AND METHODS: Nanoparticle-loaded sodium alginate microspheres were prepared by ionotropic gelation technique using calcium chloride as a cross-linker. Synthesized microspheres were characterized using standard characterization techniques and were evaluated for biological activity against MDR strain of C. albicans. RESULTS: Characterization of microspheres by Fourier-transform infrared spectroscopy confirmed loading of Nys-MgO/CuO NPs, scanning electron microscopy (SEM) revealed rough spherical beads with a highly porous surface having an average size in the range of 8-10 µm. X-ray diffraction (XRD) analyzed its semicrystalline structure. Entrapment efficiency of Nys-MgO/CuO NPs was 80% and release kinetic study revealed sustained and prolonged release of drug in pH 5.5. Flow cytometry analysis showed yeast cell death caused by Nys-MgO/CuO MS exhibits late apoptotic features. In cytotoxicity assay 5-14 mg of microspheres did not cause hemolysis. Microspheres reduced virulence traits of C. albicans such as germ tube and biofilm formation were compromised at concentration of 5 mg/mL. Antimicrobial assessment results revealed a pronounced inhibitory effect against C. albicans. CONCLUSION: The in vitro experiments have shown promising results based on good stability, Nys-MgO/CuO NP-encapsulated microspheres can be used as a prolonged controlled release system against MDR pathogenic C. albicans.


Subject(s)
Alginates/chemistry , Candida albicans/pathogenicity , Copper/chemistry , Drug Resistance, Multiple , Magnesium Oxide/chemistry , Microspheres , Nanocomposites/chemistry , Nystatin/pharmacology , Anti-Infective Agents/pharmacology , Biofilms/drug effects , Drug Liberation , Erythrocytes/drug effects , Hemolysis/drug effects , Humans , Kinetics , Microbial Sensitivity Tests , Particle Size , Phenotype , Spectroscopy, Fourier Transform Infrared , Virulence/drug effects , Virulence Factors/metabolism , X-Ray Diffraction
2.
IET Nanobiotechnol ; 14(3): 217-223, 2020 May.
Article in English | MEDLINE | ID: mdl-32338630

ABSTRACT

This study is planned to synthesise new biocompatible, nano antimicrobial formulation against biofilm producing strains. Aqueous root extract of Arctium lappa l. was used to synthesise ceria nanoparticles (CeO2-NPs). The synthesised nanoparticles were encapsulated with nano-chitosan by sol-gel method and characterised using standard techniques. Gas chromatography-mass spectrometer of Arctium lappa l. revealed the presence of ethanol, acetone, 1- propanol, 2-methylethane, 1,1-di-ethoxy, 1-Butanol, and oleic acid acted as reducing and surface stabilising agents for tailoring morphology of CeO2-NPs. Erythrocyte integrity after treatment with synthesised nanomaterials was evaluated by spectrophotometer measurement of haemoglobin release having biocompatibility. Scanning electron microscopy revealed the formation of mono dispersed beads shaped particles with mean particle size of 26.2 nm. X-ray diffractometry revealed cubic crystalline structure having size of 28.0 nm. After encapsulation by nano-chitosan, the size of CeO2-NPs enhances to 48.8 nm making average coverage of about 22.6 nm. The synthesised nanomaterials were found effective to disrupt biofilm of S. aureus and P. aeruginosa. Interestingly, encapsulated CeO2-NPs revealed powerful antibacterial and biofilm disruption activity examined by fluorescent live/dead staining using confocal laser scanning microscopy. The superior antibacterial activities exposed by encapsulated CeO2-NPs lead to the conclusion that they could be useful for controlling biofilm producing multidrug resistance pathogens.


Subject(s)
Anti-Bacterial Agents , Arctium/chemistry , Biofilms/drug effects , Metal Nanoparticles/chemistry , Plant Extracts , Anti-Bacterial Agents/chemistry , Anti-Bacterial Agents/metabolism , Anti-Bacterial Agents/pharmacology , Bacteria/drug effects , Cerium/chemistry , Cerium/metabolism , Cerium/pharmacology , Chitosan/chemistry , Drug Compounding , Erythrocytes/drug effects , Humans , Metal Nanoparticles/toxicity , Particle Size , Plant Extracts/chemistry , Plant Extracts/metabolism
3.
Pak J Pharm Sci ; 31(4(Supplementary)): 1549-1553, 2018 Jul.
Article in English | MEDLINE | ID: mdl-30058547

ABSTRACT

Bacterial resistance is spreading globally due to excessive use of antibiotics, making it one of our times biggest challenges. To address this issue present study was conducted to evaluate the antibacterial activity of copper oxide nanoparticles against methicillin-resistant S. aureus (MRSA). Copper oxide nanoparticles were synthesized by chemical precipitation method and were characterized by UV-Visible, FT-IR spectroscopy, X-ray diffraction (XRD) and Scanning Electron Microscopy. These nanoparticles of 27nm were assessed for antibacterial activity using disc diffusion method. Our results showed superb inhibitory effects of CuO nanoparticles with increase in concentration and complete inhibition was recorded against tested strains of S. aureus at 100µl/ml and 125µl/ml concentration. The study concludes that the drugs which do not show any inhibitory effects against resistant bugs could be augmented with CuO nanoparticles to achieve the treatment goal.


Subject(s)
Anti-Bacterial Agents/chemical synthesis , Anti-Bacterial Agents/pharmacology , Copper/pharmacology , Metal Nanoparticles/administration & dosage , Methicillin-Resistant Staphylococcus aureus/drug effects , Copper/chemistry , Drug Evaluation, Preclinical/methods , Humans , Metal Nanoparticles/chemistry , Methicillin-Resistant Staphylococcus aureus/physiology , Microbial Sensitivity Tests/methods
4.
Protein Pept Lett ; 25(7): 619-625, 2018.
Article in English | MEDLINE | ID: mdl-29956606

ABSTRACT

BACKGROUND: For about 30 years Human Immunodeficiency Virus (HIV) has been a significant social and health issue. It has been a perilous opponent in the human contest against HIV. At the end of 2015 there were 26.7 million people worldwide who were affected by the Human Immunodeficiency Virus (HIV) and this number is expected to increase. Unfortunately, currently there are no vaccines available for prevention and control of HIV. The global burden of HIV articulates the need for anti-HIV therapeutic factors. Venom toxins are commonly prescribed for treatment of various medical disorders. Honey Bee venom has recently been proven to be safe and maybe therapeutic in a specified dose. This therapeutic effect is due to the uptake of melittin by HIV infected cells which leads to decreased HIV gene expression and replication. Similarly, Scorpion venom acts as a therapeutic agent against HIV. Snake venoms have antiviral activity against defense mechanisms of viruses. CONCLUSION: Antiretroviral therapy is promising in the fight against HIV because it limits viral replication. It has the potential to reduce the passage of HIV-1 and to limit the viral load in infected people. This review aims to shed light on an infectious potential of active constituents of bee, scorpion and snake venom articulated in many recent studies.


Subject(s)
Bee Venoms , HIV Infections/drug therapy , Snake Venoms , Animals , Anti-HIV Agents/pharmacology , Anti-HIV Agents/therapeutic use , Antimicrobial Cationic Peptides/pharmacology , Antimicrobial Cationic Peptides/therapeutic use , Bee Venoms/pharmacology , Bee Venoms/therapeutic use , HIV-1/drug effects , Humans , Snake Venoms/pharmacology , Snake Venoms/therapeutic use
5.
Biomed Res Int ; 2018: 6147380, 2018.
Article in English | MEDLINE | ID: mdl-29568759

ABSTRACT

The use of microbial technologies in agriculture is currently expanding quite rapidly with the identification of new bacterial strains, which are more effective in promoting plant growth. In the present study 18 strains of Pseudomonas were isolated from soil sample of Balochistan coastline. Among isolated Pseudomonas strains four designated as SP19, SP22, PS24, and SP25 exhibited biocontrol activities against phytopathogenic fungi, that is, Rhizopus microsporus, Fusarium oxysporum, Aspergillus niger, Alternaria alternata, and Penicillium digitatum; PS24 identified as Pseudomonas aeruginosa by 16srRNA gene bank accession number EU081518 was selected on the basis of its antifungal activity to explore its potential as plant growth promotion. PS24 showed multiple plant growth promoting attributes such as phosphate solubilization activity, indole acetic acid (IAA), siderophore, and HCN production. In order to determine the basis for antifungal properties, antibiotics were extracted from King B broth of PS24 and analyzed by TLC. Pyrrolnitrin antibiotic was detected in the culture of strain PS24. PS24 exhibited antifungal activities found to be positive for hydrogen cyanide synthase Hcn BC gene. Sequencing of gene of Hcn BC gene of strain PS24 revealed 99% homology with the Pseudomonas aeruginosa strain PA01. The sequence of PS24 had been submitted in gene bank accession number KR605499. Ps. aeruginosa PS24 with its multifunctional biocontrol possessions can be used to bioprotect the crop plants from phytopathogens.


Subject(s)
Antifungal Agents/isolation & purification , Plant Diseases/prevention & control , Plant Growth Regulators/pharmacology , Pseudomonas aeruginosa/isolation & purification , Pseudomonas aeruginosa/physiology , Anti-Bacterial Agents/isolation & purification , Anti-Bacterial Agents/pharmacology , Antifungal Agents/pharmacology , Plant Development/drug effects , Plant Diseases/microbiology , Soil Microbiology
6.
Pak J Pharm Sci ; 30(5(Supplementary)): 1997-2002, 2017 Sep.
Article in English | MEDLINE | ID: mdl-29105634

ABSTRACT

This study was planned in order to investigate effective essential oils to inhibit in-vitro growth of Methicillin resistant Staphylococcus aureus (MRSA). In this study using disc diffusion method anti MRSA activity of ten diverse essential oils extracted from traditional plants namely Thymus vulgaris L, Mentha pulegium, Ocimum sanctum, Mentha piperita, Cymbopogon citratus, Rosmarinus officinalis L., Cortex cinnamom, Citrus nobilis x Citrus deliciosa, Origanum vulgare and Mentha sp. was examined. All the essential oils inhibited growth of S. aureus to different extent, by exhibiting moderate to elevated zones of inhibitions. Essential oils of cinnamon (Cortex cinnamomi) and thyme (Thymus vulgaris L) were observed to be the most powerful against MRSA strains used in this study. At lowest concentration of 25µl/ml essential oils comprehensible zone of inhibition was found 9±0.085mm and 8±0.051mm respectively, and at elevated concentrations there was a total decline in growth of MRSA and a very clear zone of inhibition was observed. A synergistic effect of essential oils in amalgamation with amoxicillin a Penicillin group of antibiotic was also examined. Interestingly a strong synergism was observed with oregano (Origanum vulgare) and pennyroyal mint (Mentha pulegium) essential oils, which were not so effective alone driven out to be important synergistic candidate. Our results demonstrated that essential oils of cinnamon and thyme can be used as potential antimicrobial agent against the Methicillin-resistant Staphylococcus aureus infections and Amoxicillin antibacterial activity can be enhanced using active constituents present in oregano and pennyroyal mint essential oils.


Subject(s)
Anti-Bacterial Agents/pharmacology , Cinnamomum zeylanicum , Cyclohexanones/pharmacology , Mentha pulegium , Methicillin-Resistant Staphylococcus aureus/drug effects , Oils, Volatile/pharmacology , Origanum , Penicillins/pharmacology , Plant Oils/pharmacology , Thymus Plant , Anti-Bacterial Agents/isolation & purification , Cinnamomum zeylanicum/chemistry , Cyclohexanones/isolation & purification , Disk Diffusion Antimicrobial Tests , Drug Synergism , Drug Therapy, Combination , Mentha pulegium/chemistry , Methicillin-Resistant Staphylococcus aureus/growth & development , Oils, Volatile/isolation & purification , Origanum/chemistry , Plant Oils/isolation & purification , Thymus Plant/chemistry
7.
FEMS Microbiol Lett ; 213(1): 1-6, 2002 Jul 16.
Article in English | MEDLINE | ID: mdl-12127480

ABSTRACT

Airborne bacteria isolated from a tannery air environment were screened for the property of solubilization of insoluble zinc oxide and zinc phosphate. Out of 10 strains tested, a strain of Pseudomonas aeruginosa (CMG 823) showed the best solubilization and solubilized both zinc oxide and zinc phosphate. Colonies of the bacterium produced clear haloes on solid medium which contained these insoluble metal compounds, but only when glucose was provided as a carbon source. Solubilization of zinc oxide and phosphate was accompanied by an increase in the H+ concentration of the medium, probably a consequence of the production of 2-ketogluconic acid.


Subject(s)
Air Microbiology , Pseudomonas aeruginosa/metabolism , Zinc/metabolism , Gluconates/metabolism , Hydrogen-Ion Concentration , Metals , Microbial Sensitivity Tests , Pseudomonas aeruginosa/growth & development , Pseudomonas aeruginosa/isolation & purification , Solubility , Zinc Oxide/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...